| Document |
Document Title |
|
WO/2021/113343A1 |
Disclosed herein are devices and methods for delivering a fluidic composition across a dermal barrier of a subject, e.g., into the lymphatic vasculature of the subject. In some embodiments, the devices and methods provide improved and/or...
|
|
WO/2021/109004A1 |
A transmission mechanism and a drug delivery device. The transmission mechanism comprises: an upper cover (1) provided with a sliding slot (11), connecting parts (13) located on two sides of the sliding slot (11) being provided on one si...
|
|
WO/2021/109006A1 |
Disclosed is a medicinal liquid introduction head, comprising: an introduction head body, wherein an end face of one end thereof forms a working face, and the introduction head body is integrally formed by means of injection molding; and...
|
|
WO/2021/113545A1 |
Microstructure manufacturing apparatuses and methods are disclosed herein that enable the production of microstructures in an efficient, cost-effective manner that produces precise, high- quality microstructure products. In the manufactu...
|
|
WO/2021/113585A1 |
Methods, devices and systems for delivery of an anti-PD-1 or an anti-PD-L1 therapeutic agent to the lymphatic system for treating cancer in a patient are described.
|
|
WO/2021/104296A1 |
A drug-loaded implanted medical device (10) and a preparation method therefor. The drug-loaded implanted medical device (10) comprises a device body (100), a hydrophilic coating layer (200) loaded on the device body (100), and crystallin...
|
|
WO/2021/108210A1 |
A benefit agent delivery system whereby benefit agents can be delivered on demand and/or a variety of different benefit agents at different concentrations can be delivered from the same system. The benefit agent delivery system includes ...
|
|
WO/2021/107405A1 |
Disclosed is a microparticle control device using the force of a magnetic field. Provided according to one aspect of the present embodiment is a microparticle control device capable of monitoring microparticles injected in an object or a...
|
|
WO/2021/100316A1 |
Provided is a drug solution diffusing system (1) for diffusing a drug solution to subject tissue inside a living body, the drug solution diffusing system (1) comprising a drug solution injecting tube (3) to be pierced into the subject ti...
|
|
WO/2021/102369A1 |
The application provides a dissolvable microneedle device to deliver immune stimulants to the skin. The application also provides a method of treating a skin condition comprising applying a dissolvable microneedle device to the skin.
|
|
WO/2021/097224A1 |
The presently disclosed drug-loaded liposomal conjugated to polymer microbubbles showed: i) increased tumor drug concentration; ii) reduced tumor growth; and ii) increased survival time in a mouse cancer model when exposed to concurrent ...
|
|
WO/2021/093789A1 |
A wristband-type biological signal acquisition device (200) and a manufacturing method therefor. Said device comprises a wristband (201, 301), a micro-needle array (202, 3022) formed on a micro-needle array substrate, and a biological si...
|
|
WO/2021/093762A1 |
A vortexed-acoustic-field method for creating cell permeability and a vortexed-acoustic-field method for opening a blood-brain barrier. The vortexed-acoustic-field method for creating cell permeability comprises: using an ultrasonic tran...
|
|
WO/2021/094924A1 |
Presented herein are techniques for localized release of systemically circulating therapeutic substances, which combine many of the advantages of systematic and localized administration, while eliminating many of the associated drawbacks...
|
|
WO/2021/085980A1 |
The present invention relates to an apparatus using an oxidation-reduction reaction and a drug delivery method using same. The present invention comprises: a base sheet; first electrode patterns which are disposed on the base sheet and a...
|
|
WO/2021/086123A1 |
The present invention relates to a microstructure formulation technique for botulinum toxin. The microstructure formulation technique for botulinum toxin according to the present invention enables the concentration of botulinum toxin to ...
|
|
WO/2021/085979A1 |
The present invention relates to an apparatus using reverse electrodialysis and a redox reaction and a method for delivering a drug by using same. The present invention comprises: a base sheet; a first electrode pattern provided in one r...
|
|
WO/2021/085564A1 |
An accelerator module is connected to an initiator module and generates supersonic waves from subsonic waves generated by the initiator module. The supersonic waves deliver particles to cells in tissues. The accelerator module may includ...
|
|
WO/2021/087179A1 |
A drug delivery system is described comprising a detachable support and a plurality of drug-loaded transdermal microneedles, for delivering drugs into gingival tissue for the treatment of periodontal disease.
|
|
WO/2021/085565A1 |
This wearable multi-shot injection patch comprises: a base that has a bottom surface and a top surface and is configured so that the bottom surface is disposed against a patient's skin; a first container that is supported by the base and...
|
|
WO/2021/078982A1 |
A product for cosmetic skin care, comprising an applicator (10) and an active-care cosmetic composition. The applicator is constituted by an ergonomic metallic body (11) adapted for skin contact, in which a permanent magnet (14) with mag...
|
|
WO/2021/081252A1 |
The present invention relates to a vaginal drug delivery device configured to safely and effectively deliver a therapeutic formulation in the vagina at or near a desired target area for a specified time period.
|
|
WO/2021/081392A1 |
The present invention is directed to an applicator, configured to reversibly attach to a dispensing device, with at least one micropore and a kit for administration of a therapeutic agent. Methods of use of the applicator are also disclo...
|
|
WO/2021/080278A1 |
The present invention relates to an ionic massage device for skin care, the device comprising: a housing part which, while in contact with one point on the user's body, comes into contact with another point on the user's body, thereby ca...
|
|
WO/2021/074119A1 |
The invention relates to a handpiece (1), a system having a handpiece and a method using a handpiece for contacting and applying a fluid to human skin. The handpiece comprises an ultrasonic assembly (2) and a casing (4) surrounding the u...
|
|
WO/2021/077111A1 |
The present invention provides a method for treating a disease or condition in a subject, comprising administering to the subject's skin a composition comprising an effective amount of one or more cannabinoids, wherein the composition is...
|
|
WO/2021/075630A1 |
The present invention relates to a liquid dispenser and, more specifically, to a liquid dispenser which enables a liquid cosmetic solution such as essence to easily permeate a user's skin along a gear-type needle part while the gear-type...
|
|
WO/2021/074790A1 |
Provided is a transdermal drug delivery system comprising cannabidiol, or its salt alone or in combinations thereof. Transdermal delivery can provide a drug plasma concentration at predetermined rate for a predetermined period of time wi...
|
|
WO/2021/077114A1 |
The present invention provides a method for treating a disease or condition in a subject, comprising administering to the subject's skin a composition comprising an effective amount of exosomes, wherein the composition is administered wi...
|
|
WO/2021/071780A1 |
The devices (100, 200, 300, 400, 500, 600), assemblies, and methods described herein utilize photoacoustic principals to create a jet of fluid using a ultrasonic resonance member (126, 226, 326, 426, 526, 626) and a pulsed laser light be...
|
|
WO/2021/070120A1 |
The preparation of transdermal pharmaceutical compositions comprising cannabidiol (CBD) and use thereof in the treatment of seizure disorders is disclosed. Preferably, the CBD is provided in the form of a highly purified extract of canna...
|
|
WO/2021/069938A1 |
The invention is a personal care compact device (gadget) comprised of a scratching jaw for skin (4) and a depositor of immune aids (3) that is either a porous mass or a vial. It is claimed that controlled exposure of body to microbes/vir...
|
|
WO/2021/071462A2 |
The present invention relates to the temporary tattoo method applied on human body, furniture, and vehicles by use of neon paint that is visible at night and is not harmful for human health by way of spraying.
|
|
WO/2021/071097A1 |
An implantable substance delivery vehicle of the present invention comprises: a pin comprising a bevel tip and an engraved groove on the surface of the bevel tip; and a substance to be delivered into the body, inserted so as to protrude ...
|
|
WO/2021/070568A1 |
A microneedle sheet according to one embodiment is provided with: a sheet body having a main surface; and one or more microneedles formed on the sheet body and lying along the main surface. Each of the one or more microneedles has a base...
|
|
WO/2021/066747A1 |
Herein disclosed is a therapeutics delivery device implantable in a biological tissue, including a core which is biodegradable, wherein the core includes a first polymer composition, wherein the core has a height of at least 1 mm, and wh...
|
|
WO/2021/062494A1 |
A nebuliser for nebulising liquid droplets, including: a housing; at least one piezoelectric substrate (2) accommodated within the housing and having a transducer surface (2a) upon which is located at least one electroacoustic transducer...
|
|
WO/2020/068842A9 |
An embodiment of an ingestible device for the delivery of a therapeutic agent includes a swallowable outer shell and a delivery mechanism within the outer shell. The delivery mechanism includes an expandable enclosure. The delivery mecha...
|
|
WO/2021/061822A1 |
The present invention provides a method for treating a skin neoplasm in a subject, comprising administering to the subject's skin a composition comprising an effective amount of one or more antineoplastic agents, wherein the composition ...
|
|
WO/2021/053079A2 |
The invention relates to a microneedle, in particular for transdermal and/or intradermal administration of active substances, having a supporting structure and having at least one needle structure arranged on the supporting structure for...
|
|
WO/2021/055445A1 |
A retractor for use in surgical operations comprises a first blade, a second blade, and a third blade. In operation, the blades are initially in a closed position to assume a low profile during insertion. The blades can be independently ...
|
|
WO/2021/054649A1 |
A mask according to an embodiment comprises: a body having a shape corresponding to a user's face; a first recess disposed on one surface of the body, opposite to the user's face; and a piezoelectric part disposed in the first recess, wh...
|
|
WO/2021/050404A1 |
The disclosed subject matter relates to a system and method for delivery of therapeutic agents across membranes such as to the inner ear. The system includes a plurality of metal microneedles which can be delivered to the round window me...
|
|
WO/2021/047629A1 |
Disclosed is a composition for lightening spots, comprising the following components in weight percentage: 0.5-50％ of a tranexamic acid; 0.1-20％ of a hydrophilic solubilizer; and 30-95％ of a water-soluble matrix material. When the ...
|
|
WO/2021/049584A1 |
The purpose of the present invention is to provide a device which, in a shallow area comprising the epidermal layer or the dermal layer, can administer a target even in extremely small amounts. This device 100 for administering a drug in...
|
|
WO/2021/047628A1 |
Disclosed is a sustained-release microneedle patch and a preparation method therefor, which relates to the field of medical technology. The microneedle patch comprises a needle body and a needle tip on the needle body, wherein the needle...
|
|
WO/2021/046001A1 |
A method and apparatus for delivery of cell therapies, introduced via percutaneous access to the circulation, and delivered to the site of vascular injury or intervention.
|
|
WO/2021/036076A1 |
A quantitative liquid supply device, comprising a housing (20) and a liquid medicine introducing head (10) mounted at one end of the housing (20), and further comprising a transmission mechanism, a power mechanism (23), and a power sourc...
|
|
WO/2021/037860A1 |
An injector system (500) for injection by puncture of an organ, of a non-deformable medical implant (200) into a subject comprising: a holding element (100) having a proximal (10) and distal (20) end disposed with a chamber (102) for con...
|
|
WO/2021/038572A1 |
The present disclosure provides with a device for temporary residence at an ileocecal valve of a subject, the device having a trapping configuration, wherein in the trapping configuration, the device is configured to be retained at the i...
|
